Skip to content

Septerna, Inc. SEPN Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$189.67B+13.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.93B+436%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.5B+309%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.64B+40.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$880.77M+29.3%
Precigen logo
PrecigenPGEN
$1.37B+213%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Enterprise value$1.6B+1,325%
P/S22.8×-379×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Computed from the period-end share price: $1.08B.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s market capitalization?
Septerna, Inc. (SEPN) reported market capitalization of $1.08B in Q1 2026.
How has Septerna, Inc.'s market capitalization changed year-over-year?
Septerna, Inc.'s market capitalization increased by 319.4% year-over-year, from $257.32M to $1.08B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.